Related Experiment Video
Updated: Jun 16, 2026

05:39
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
385
Dupilumab for pediatric prurigo nodularis: A case report
Tahel Fachler1, Sofia Maria Faitataziadou1, Vered Molho-Pessach1
1Department of Dermatology, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Pediatric Dermatology
|November 28, 2020
Abstract:
Herein we report on a 9-year-old girl with recalcitrant prurigo nodularis unresponsive to multiple standard treatments. She was started on dupilumab therapy with rapid improvement in pruritus within 2 weeks and near complete regression of lesions at 3 months. Dupilumab should be considered as an off-label treatment for refractory prurigo nodularis in children.

